WallStreetZen

NYSE: MRK
Merck & Co Inc Stock

$76.53+0.14 (0.18%)
Updated Jul 22, 2021
MRK Price
$76.53
Fair Value Price
N/A
Market Cap
$193.78B
52 Week Low
$71.72
52 Week High
$87.80
P/E
27.53x
P/B
7.19x
P/S
4.06x
PEG
0.77x
Dividend Yield
3.35%
Revenue
$48.02B
Earnings
$7.03B
Gross Margin
67%
Operating Margin
17.48%
Profit Margin
14.6%
Debt to Equity
2.37
Operating Cash Flow
$11B
Beta
0.67
Next Earnings
Jul 29, 2021
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

High
Medium
Low
55
Industry average

Reasons for this score

MRK ($76.53) is trading below its intrinsic value of $352.60, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
MRK is good value based on its earnings relative to its share price (27.53x), compared to the US market average 28.43x)
Valuation
MRK is good value based on its earnings relative to its share price (27.53x), compared to the US Drug Manufacturers - General industry average (33.42x)
Valuation

1 of 13

MRK News

Valuation

MRK price to earnings (PE)

For valuing profitable companies with steady earnings
Company
27.53x
Industry
33.42x
Market
28.43x
MRK is good value based on its earnings relative to its share price (27.53x), compared to the US market average 28.43x)
Valuation
MRK is good value based on its earnings relative to its share price (27.53x), compared to the US Drug Manufacturers - General industry average (33.42x)
Valuation

MRK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
7.19x
Industry
5.4x
MRK is poor value based on its book value relative to its share price (7.19x), compared to the US Drug Manufacturers - General industry average (5.4x)
Valuation

MRK price to earnings growth (PEG)

For valuing profitable companies with growth potential
MRK is good value based on it's Price to Earnings and rate of earnings growth, measured by PEG ratio (0.77x)
Valuation

MRK's financial health

Profit margin

Revenue
$12.1B
Net Income
$3.2B
Profit Margin
26.3%
MRK's Earnings (EBIT) of $8.39B can safely cover interest payments on company debt ($31.25B)
Financials
MRK's profit margin has decreased (-6.5%) in the last year from (21.1%) to (14.6%)
Financials

Assets to liabilities

Assets
$90.8B
Liabilities
$63.8B
Debt to equity
1.16
MRK's short-term assets ($26.91B) exceed its short-term liabilities ($26.36B)
Financials
MRK's long-term liabilities ($37.45B) exceed its short-term assets ($26.91B)
Financials
MRK's debt has increased relative to shareholder equity (2.37), over the past 5 years ago (1.25)
Financials
MRK's debt to equity ratio (2.37) is considered high
Financials

Cash flow

Operating
$1.8B
Investing
-$738.0M
Financing
-$2.1B
MRK's operating cash flow ($11.34B) is sufficient to service the company's debt ($31.25B)
Financials

Merck & Stock FAQ

What is Merck &'s quote symbol?

(NYSE: MRK) Merck & trades on the NYSE under the ticker symbol MRK. Merck & stock quotes can also be displayed as NYSE: MRK.

What is the 52 week high and low for Merck & (NYSE: MRK)?

(NYSE: MRK) Merck &'s 52-week high was $87.80, and its 52-week low was $71.72. It is currently -12.84% from its 52-week high and 6.71% from its 52-week low.

How much is Merck & stock worth today?

(NYSE: MRK) Merck & currently has 2,532,058,364 outstanding shares. With Merck & stock trading at $76.53 per share, the total value of Merck & stock (market capitalization) is $193.78B.

Merck & stock was originally listed at a price of $53.00 in Dec 31, 1997. If you had invested in Merck & stock at $53.00, your return over the last 23 years would have been 44.4%, for an annualized return of 1.61%.

How much is Merck &'s stock price per share?

(NYSE: MRK) Merck & stock price per share is $76.53 today (as of Jul 22, 2021).

What is Merck &'s Market Cap?

(NYSE: MRK) Merck &'s market cap is $193.78B, as of Jul 23, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Merck &'s market cap is calculated by multiplying MRK's current stock price of $76.53 by MRK's total outstanding shares of 2,532,058,364.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.